🔎 Trials Near Me

Akèy › Maladi Alzheimer › Maryland

Etid klinik pou Maladi Alzheimer nan Maryland

13 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan Maryland.

Vil nan Maryland

Tèks ofisyèl etid la (Anglè)

Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging

  • National Institute of Aging, Clinical Research Unit, Baltimore
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 55 a 110 · Tout sèks · Mizajou Oct 5, 2026 · NCT07099053

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

  • Local Institution - 1636, Gaithersburg
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 28, 2026 · NCT06937229

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

  • Headlands PharmaSite, Pikesville
Ap rekriteFaz 2
Laj 55 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT06847321

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

  • National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 99 · Tout sèks · Mizajou Sep 18, 2026 · NCT04396873

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

  • CBH Health, Gaithersburg
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 16, 2026 · NCT07011732

Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive Decline

  • Johns Hopkins Hospital, Baltimore
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT05556395

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

  • Johns Hopkins Center for Psychedelic and Consciousness Research, Baltimore
Ap rekriteFaz 1 bonè
Laj 18 a 85 · Tout sèks · Mizajou Sep 4, 2026 · NCT04123314

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • University of Maryland Medical Center, Baltimore
  • Johns Hopkins University, Baltimore
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895

Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)

  • Johns Hopkins School of Medicine, Baltimore
Ap rekriteFaz 2Volontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT04601038

Music Therapy for Patients With Alzheimer's Disease

  • Johns Hopkins School of Medicine, Baltimore
Ap rekrite
Laj 18 a 89 · Tout sèks · Mizajou May 6, 2026 · NCT05151562

Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease

  • Johns Hopkins School of Medicine, Baltimore
Ap rekrite
Laj 60 ak plis · Tout sèks · Mizajou Jan 29, 2026 · NCT05795634

Vestibular Therapy in Alzheimer's Disease

  • Johns Hopkins University School of Medicine, Baltimore
Ap rekrite
Laj 60 ak plis · Tout sèks · Mizajou Jan 12, 2026 · NCT03799991

HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms

  • Johns Hopkins Memory and Alzheimer's Treatment Center, Baltimore
Ap rekriteVolontè an sante akeyi
Laj 60 a 100 · Tout sèks · Mizajou Nov 24, 2025 · NCT06930560

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.